首页> 外文OA文献 >Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center

【2h】

Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center

机译：谁有资格进行随机试验？ ISCHEMIA试验定义的排除标准与3102名在单个心脏病中心接受支架植入的稳定冠状动脉疾病的现实世界患者的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center [J] . Jaros?aw Wasilewski, Lech Poloński, Andrzej Lekston, Trials . 2015,第1期

机译：谁有资格进行随机试验？在ISCHEMIA试验定义的排除标准与3102名在单个心脏病学中心接受支架植入的稳定冠状动脉疾病的现实世界患者之间的比较
2. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study [J] . Matsumura-Nakano Yukiko, Shizuta Satoshi, Komasa Akihiro, Circulation: An Official Journal of the American Heart Association . 2019,第5期

机译：在冠状动脉支架植入后1年后，在冠状动脉支架术后1年内与心房颤动和稳定冠状动脉疾病患者进行口服抗凝治疗的开放标签随机试验比较口服抗凝血治疗
3. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. [J] . Stables R The Lancet . 2002,第9338期

机译：多支冠状动脉疾病患者的冠状动脉搭桥手术与经皮冠状动脉支架置入术（支架或手术试验）：一项随机对照试验。
4. Selected Markers of Inflammation and Endothelial Dysfunction in Patients with Stable Coronary Artery Disease Treated with PTCA with/without Stent Implantation [C] . W. Kolasinska-Kloch, D. Drobniak-Heldak, M. Kloch, International Congress on Coronary Artery Disease . 2007

机译：用PTCA处理稳定冠状动脉疾病患者的炎症和内皮功能障碍的标记，用/无支架植入
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center [O] . Jarosław Wasilewski, Lech Poloński, Andrzej Lekston, 2015

机译：谁有资格进行随机试验？在ISCHEMIA试验定义的排除标准与3102名在单个心脏病中心接受支架植入的稳定冠状动脉疾病的现实世界患者之间的比较
7. Randomized comparison of six versus twenty-four months clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all comer patients undergoing percutaneous coronary intervention. Results of the PRODIGY Trial 1M.ValgimigliG.CampoG.Percoco(PRODIGY Investigators)Randomized comparison of six versus twenty-four months clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all comer patients undergoing percutaneous coronary intervention. Results of the PRODIGY Trial2011European Society of Cardiology Scientific CongressParis [O] . Subban Vijayakumar 2012

机译：在所有接受经皮冠状动脉介入治疗的角膜癌患者平衡抗内膜增生支架效价后，对六个月与二十四个月的氯吡格雷治疗进行随机比较。 PRODIGY试验1M.ValgimigliG.CampoG.Percoco（PRODIGY Investigators）的结果对所有接受经皮冠状动脉介入治疗的角膜内膜增生支架效能达到平衡后的六个月与二十四个月的氯吡格雷治疗进行了随机对照比较。 PRODIGY试验的结果2011年欧洲心脏病学会科学大会巴黎

Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center

著录项

相似文献

相关主题

期刊订阅